Inicio > CALONGE CANO, MARGARITA

CALONGE CANO, MARGARITA

CATEDRATICOS DE UNIVERSIDAD
Cirugía, Oftalmología, Otorrinolaringología y Fisioterapia
GRUPO DE INVESTIGACION EN SUPERFICIE OCULAR (GSO)
 
calonge@ioba.med.uva.es
0

Índice H en Web of Science: 35
Índice H en Scopus: 38
 
Enlazar esta página

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59335]], camposKey:1542-0124 2020-10-01 Inflammatory status predicts contact lens discomfort under adverse environmental conditions829840, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52801]], camposKey:0014-4835 2020-01-01 Clinical and tear cytokine profiles after advanced surface ablation refractive surgery: A six-month follow-up00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52911]], camposKey:1542-2321 2020-01-01 Development of a Questionnaire for Detecting Changes in Dry Eye Disease-Related Symptoms00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52802]], camposKey:0929-8673 2020-01-01 Tear inflammatory molecules in contact lens wearers: A literature review523548, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41610]], camposKey:1755-375X 2019-03-01 Role of corneal nerves in ocular surface homeostasis and disease137145, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41609]], camposKey:1931-5244 2019-01-01 A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency1840, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52915]], camposKey:1699-1036 2019-01-01 Eficacia del trasplante de células madre mesenquimales de médula ósea y de tejido adiposo en un modelo de deficiencia de células madre limbares desarrollado en conejo: estudio comparativo172172, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52916]], camposKey:1699-1036 2019-01-01 Eficacia del trasplante de células madre mesenquimales de médula ósea y de tejido adiposo en un modelo de deficiencia de células madre limbares desarrollado en conejo: estudio comparativo3639, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56652]], camposKey:0146-0404 2019-01-01 Ocular Surface Pathology in Patients Suffering from Acute Intoxication with Occupational Mercury00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41608]], camposKey:0927-7765 2019-01-01 Poly-L/DL-lactic acid films functionalized with collagen IV as carrier substrata for corneal epithelial stem cells121129, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41511]], camposKey:1542-0124 2019-01-01 Response profiles to a controlled adverse desiccating environment based on clinical and tear molecule changes502515, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42955]], camposKey:0927-3948 2019-01-01 Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease10231032, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41611]], camposKey:0271-3683 2018-04-03 Controlled Adverse Environment Chambers in Dry Eye Research445450, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11553]], camposKey:0271-3683 2018-01-01 Are Contact Lens Discomfort or Soft Contact Lens Material Properties Associated with Alterations in the Corneal Sub-Basal Nerve Plexus?487492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52914]], camposKey:1699-1036 2018-01-01 Estudio de la tolerabilidad y la eficacia del trasplante de células madre mesenquimales de médula ósea en un modelo de síndrome de insuficiencia límbica189190, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37802]], camposKey:1542-0124 2018-01-01 Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial368376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3536]], camposKey:1542-0124 2018-01-01 Topical fluorometholone treatment and desiccating stress change inflammatory protein expression in tears8492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3531]], camposKey:0271-3683 2017-07-03 Clinical Features and Prognostic Factors in Presumed Ocular Tuberculosis10291034, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47865]], camposKey:0146-0404 2017-01-01 A Randomized Controlled Trial of Cultivated Limbal Epithelial Cells Compared to Mesenchymal Stem Cells for the Treatment of Corneal Failure due to Limbal Stem Cell Deficiency00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41612]], camposKey:1755-375X 2017-01-01 Cytokine and chemokine tear levels in patients with uveitis405414, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3534]], camposKey:0020-8167 2017-01-01 Effects of the external environment on dry eye disease2340, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52913]], camposKey:1699-1036 2017-01-01 Inflamación de la superficie ocular en un modelo parcial y total de síndrome de insuficiencia límbica204204, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3535]], camposKey:0275-5408 2017-01-01 Ocular response to environmental variations in contact lens wearers6070, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3529]], camposKey:0146-0404 2017-01-01 Prehematopoietic stem cell transplantation tear cytokines as potential susceptibility biomarkers for ocular chronic graft-versus-host disease48364846, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3533]], camposKey:0161-6420 2017-01-01 Reply02, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3532]], camposKey:0271-3683 2017-01-01 Successful Consecutive Expansion of Limbal Explants Using a Biosafe Culture Medium under Feeder Layer-Free Conditions685695, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3528]], camposKey:1066-5099 2017-01-01 Therapeutic Effect of Human Adipose Tissue-Derived Mesenchymal Stem Cells in Experimental Corneal Failure Due to Limbal Stem Cell Niche Damage21602174, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3543]], camposKey:0146-0404 2016-01-01 Biomarkers in ocular chronic graft versus host disease: Tear cytokine- and chemokine-based predictive model746758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3541]], camposKey:0002-9394 2016-01-01 Clinical and Molecular Inflammatory Response in Sjögren Syndrome-Associated Dry Eye Patients under Desiccating Stress00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3540]], camposKey:0014-4835 2016-01-01 Comparison of functional limbal epithelial stem cell isolation methods8394, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3537]], camposKey:1040-5488 2016-01-01 Corneal sensitivity and inflammatory biomarkers in contact lens discomfort892900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3538]], camposKey:0277-3740 2016-01-01 Effect of environmental conditions on the concentration of tear inflammatory mediators during contact lens wear11921198, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3539]], camposKey:1040-5488 2016-01-01 Lack of agreement among electrical impedance and freezing-point osmometers482487, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39503]], camposKey:0146-0404 2016-01-01 Tear fluid proteome reveals inflammation and immune response proteins as potential predictive biomarkers of the effects of desiccating stress and dry eye treatments00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3542]], camposKey:0161-6420 2016-01-01 Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial141153, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=682]], camposKey:0213-3911 2015-02-01 In vivo confocal microscopy assessment of the corneoscleral limbal stem cell niche before and after biopsy for cultivated limbal epithelial transplantation to restore corneal epithelium183192, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8939]], camposKey:1755-375X 2015-01-01 Environmental factors in ocular surface disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3547]], camposKey:0146-0404 2015-01-01 Gene expression-based predictive models of graft versus host disease-associated dry eye45704581, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49171]], camposKey:0146-0404 2015-01-01 Improvement of limbal and corneal phenotype after transplantation of human adipose tissue-derived mesenchymal stem cells in an in vivo model of ocular surface failure00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3545]], camposKey:1040-5488 2015-01-01 Influence of climate on clinical diagnostic dry eye tests: Pilot study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3544]], camposKey:0146-0404 2015-01-01 Quercetin and resveratrol decrease the inflammatory and oxidative responses in human ocular surface epithelial cells27092719, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10418]], camposKey:0146-0404 2015-01-01 Soluble hyaluronan receptor CD44 levels secreted by human conjunctival cells change in inflammatory conditions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3546]], camposKey:2314-6133 2015-01-01 Stem Cell Therapy for Corneal Epithelium Regeneration following Good Manufacturing and Clinical Procedures00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=768]], camposKey:0271-3683 2014-01-01 Basal values, intra-day and inter-day variations in tear film osmolarity and tear fluorescein clearance673679, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49168]], camposKey:0146-0404 2014-01-01 Biosafe culture medium optimization for in vitro expansion of limbal epithelial stem cells for clinical transplantation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=680]], camposKey:0721-832X 2014-01-01 CD44 and RHAMM hyaluronan receptors in human ocular surface inflammation12891295, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=788]], camposKey:0002-9394 2014-01-01 Dry Eye Exacerbation in Patients Exposed to Desiccating Stress under Controlled Environmental Conditions788798, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=759]], camposKey:1552-4973 2014-01-01 Influence of environmental factors in the in vitro dehydration of hydrogel and silicone hydrogel contact lenses764771, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=751]], camposKey:0014-4835 2014-01-01 Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects4349, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49169]], camposKey:0146-0404 2014-01-01 Safety and preliminary efficacy of human adipose tissue mesenchymal stem cells (hATMSC) to restore the ocular surface in an in vivo experimental model of limbal stem cell deficiency (LSCD)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=728]], camposKey:1542-0124 2013-10-01 Role of Hyperosmolarity in the Pathogenesis and Management of Dry Eye Disease: Proceedings of the OCEAN Group Meeting246258, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=646]], camposKey:0146-0404 2013-07-01 Mitochondrial Permeability Transition Pore in Inflammatory Apoptosis of Human Conjunctival Epithelial Cells and T Cells: Effect of Cyclosporin A47174733, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=663]], camposKey:0969-7128 2013-01-01 A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model467477, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=796]], camposKey:0957-4530 2013-01-01 Chitosan-gelatin biopolymers as carrier substrata for limbal epithelial stem cells28192829, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=755]], camposKey:0271-3683 2013-01-01 Consecutive Expansion of Limbal Epithelial Stem Cells from a Single Limbal Biopsy537549, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=729]], camposKey:0014-4835 2013-01-01 Effect of TGF-beta on ocular surface epithelial cells88100, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=694]], camposKey:0732-8893 2013-01-01 Fatal disseminated Scedosporium prolificans infection initiated by ophthalmic involvement in a patient with acute myeloblastic leukemia375378, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=779]], camposKey:0271-3683 2013-01-01 In Vitro Simulation of Corneal Epithelium Microenvironment Induces a Corneal Epithelial-like Cell Phenotype from Human Adipose Tissue Mesenchymal Stem Cells933944, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=792]], camposKey:0146-0404 2013-01-01 Influence of a Controlled Environment Simulating an In-Flight Airplane Cabin on Dry Eye Disease20932099, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=642]], camposKey:0277-3740 2013-01-01 Oculopalpebral Borreliosis as an Unusual Manifestation of Lyme Disease8790, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=674]], camposKey:0927-3948 2012-12-01 Distinctive Clinical Features of Idiopathic versus Infectious Serpiginous Choroidopathy448452, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=671]], camposKey:0146-0404 2012-04-01 Autoantibodies Contribute to the Immunopathogenesis of Experimental Dry Eye Disease20622075, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=730]], camposKey:0146-0404 2012-01-01 Characterization by Belmonte's Gas Esthesiometer of Mechanical, Chemical, and Thermal Corneal Sensitivity Thresholds in a Normal Population31543160, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=736]], camposKey:0271-3683 2012-01-01 Correlations Among Symptoms, Signs, and Clinical Tests in Evaporative-Type Dry Eye Disease Caused by Meibomian Gland Dysfunction (MGD)855863, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=780]], camposKey:1528-4050 2012-01-01 Molecular and cellular biomarkers in dry eye disease and ocular allergy523533, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=695]], camposKey:1933-0219 2012-01-01 Topographical distribution and characterization of epithelial cells and intraepithelial lymphocytes in the human ocular mucosa455467, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=789]], camposKey:1353-4505 2011-12-01 What makes hospitalized patients more vulnerable and increases their risk of experiencing an adverse event?705712, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=686]], camposKey:0041-1345 2011-06-01 Dry Eye Disease in Chronic Graft-Versus-Host Disease: Results From a Spanish Retrospective Cohort Study19341938, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=675]], camposKey:0008-4182 2011-02-01 Antioxidant enzyme mRNA expression in conjunctival epithelium of healthy human subjects3539, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=703]], camposKey:1090-0535 2011-01-01 A comparison of stem cell-related gene expression in the progenitor-rich limbal epithelium and the differentiating central corneal epithelium21022117, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=746]], camposKey:0146-0404 2011-01-01 Activation of MAPK Signaling Pathway and NF-kappa B Activation in Pterygium and Ipsilateral Pterygium-Free Conjunctival Specimens58425852, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=766]], camposKey:1040-5488 2011-01-01 Contact Lens Case Cleaning Procedures Affect Storage Solution pH and Osmolality14141421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=717]], camposKey:0146-0404 2011-01-01 Differential Cell Proliferation, Apoptosis, and Immune Response in Healthy and Evaporative-Type Dry Eye Conjunctival Epithelia48194828, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=757]], camposKey:1090-0535 2011-01-01 Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells279290, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3550]], camposKey:1177-5467 2011-01-01 Intraocular inflammation as the main manifestation of Rickettsia conorii infection14011407, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3551]], camposKey:0365-6691 2011-01-01 Lack of concordance between dry eye syndrome questionnaires and diagnostic tests Falta de concordancia entre los cuestionarios y las pruebas diagnósticas en el síndrome de ojo seco37, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=772]], camposKey:0146-0404 2011-01-01 Ocular Mucin Gene Expression Levels as Biomarkers for the Diagnosis of Dry Eye Syndrome83638369, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29497]], camposKey:0212-4394 2011-01-01 Procedimientos de valoración de la función visual en el síndrome de ojo seco3539, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=786]], camposKey:0730-2312 2011-01-01 Regulation of Dab2 Expression in Intestinal and Renal Epithelia by Development354361, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46973]], camposKey:1869-5760 2011-01-01 Surgical outcomes of uveitic glaucoma4353, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29496]], camposKey:2173-9366 2011-01-01 Técnicas diagnósticas para el síndrome de ojo seco (I)1220, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=672]], camposKey:1350-9462 2010-11-01 Applications of nanoparticles in ophthalmology596609, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=635]], camposKey:1933-0219 2010-09-01 Autoimmunity at the ocular surface: pathogenesis and regulation425442, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50860]], camposKey:1560-2133 2010-01-01 Choroidal neovascularisation in punctate inner choroidopathy: therapeutic options.1928, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=742]], camposKey:1755-375X 2010-01-01 Cytokine and chemokine levels in tears from healthy subjects00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=790]], camposKey:0927-3948 2010-01-01 Dry Eye Disease as an Inflammatory Disorder244253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=760]], camposKey:0277-3740 2010-01-01 Ocular Tolerance to a Topical Formulation of Hyaluronic Acid and Chitosan-Based Nanoparticles550558, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=731]], camposKey:1090-0535 2010-01-01 Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease862873, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=683]], camposKey:0014-4835 2009-08-01 Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone238245, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=664]], camposKey:1542-0124 2009-04-01 Immunoregulation on the Ocular Surface: 2nd Cullen Symposium6777, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=661]], camposKey:1090-0535 2009-01-01 Characterization and short-term culture of cells recovered from human conjunctival epithelium by minimally invasive means21852195, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=719]], camposKey:1052-2166 2009-01-01 Comparison of Gene Expression Profiles of Conjunctival Cell Lines With Primary Cultured Conjunctival Epithelial Cells and Human Conjunctival Tissue265278, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=784]], camposKey:1040-5488 2009-01-01 Conjunctival Mucin mRNA Expression in Contact Lens Wear10511058, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=310]], camposKey:0271-3683 2009-01-01 Genetically Engineered Elastin-Like Polymer as a Substratum to Culture Cells from the Ocular Surface4856, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=638]], camposKey:0146-0404 2008-12-01 In Vitro Expanded CD4(+)CD25(+)Foxp3(+) Regulatory T Cells Maintain a Normal Phenotype and Suppress Immune-Mediated Ocular Surface Inflammation54345440, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=777]], camposKey:1043-4666 2008-01-01 Cytokine responses by conjunctival epithelial cells: An in vitro model of ocular inflammation160167, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=666]], camposKey:1744-666X 2008-01-01 Cytokines and chemokines in immune-based ocular surface inflammation457467, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3553]], camposKey:0365-6691 2008-01-01 Limbal transplantation: Multicenter retrospective case series analysis Estudio multicéntrico retrospectivo sobre trasplante de limbo417422, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=677]], camposKey:1528-4050 2007-10-01 Clinical grading of atopic keratoconjunctivitis442445, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11096]], camposKey:0098-8243 2007-06-01 Conjunctival pigmentation in Stevens-Johnson syndrome99103, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=787]], camposKey:0105-4538 2007-06-01 Nonspecific provocation of target organs in allergic diseases: EAACI-GA(2)LEN consensus report683694, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=705]], camposKey:1530-4086 2007-03-01 Conjunctival pigmentation in Stevens-Johnson syndrome152157, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=668]], camposKey:0179-1958 2007-03-01 Subretinal fibrosis and uveitis syndrome associated with ulcerative colitis333334, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=764]], camposKey:0146-0404 2007-01-01 Exposure to a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye40264032, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29868]], camposKey:0212-4394 2007-01-01 Líneas de investigación del Grupo de Superficie Ocular del IOBA218220, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3554]], camposKey:1542-0124 2007-01-01 Methodologies to diagnose and monitor dry eye disease: Report of the diagnostic methodology subcommittee of the international Dry Eye Workshop (2007)108152, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=716]], camposKey:0142-9612 2007-01-01 Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)15531564, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=29869]], camposKey:0212-4394 2007-01-01 Sensibilidad corneal: una medida clave para la salud ocular618626, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=656]], camposKey:1462-0324 2006-12-01 Severe keratopathy in paediatric Cogan's syndrome15761577, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=771]], camposKey:0003-9950 2006-01-01 Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis462468, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=767]], camposKey:0146-0404 2006-01-01 Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance14161425, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=665]], camposKey:1528-4050 2006-01-01 Muscarinic receptors in the ocular surface379382, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41614]], camposKey:1560-2133 2005-07-21 Dry eye disease: Current therapies and related systemic diseases1215, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=649]], camposKey:1058-4838 2005-03-01 Cat-scratch disease (ocular bartonellosis) presenting as bilateral recurrent iridocyclitis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=765]], camposKey:0021-9541 2005-03-01 OCTN3: A Na+-independent L-carnitine transporter in enterocytes basolateral membrane929935, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=750]], camposKey:0271-3683 2005-01-01 Alpha(2)-Adrenergic receptors are present in normal human conjunctiva11211129, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56142]], camposKey:0146-0404 2005-01-01 Can ocular mucin gene levels be used as an Investigational diagnostic test for dry eye?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41613]], camposKey:1542-0124 2005-01-01 Evaluation of ocular surface inflammation in the presence of dry eye and allergic conjunctival disease161164, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=754]], camposKey:0146-0404 2005-01-01 Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium504513, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56649]], camposKey:0146-0404 2005-01-01 Inflammatory cytokine effects on co-stimulatory molecule and chemokine expression in the human conjunctival epithelial cell line, IOBA-NHC00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56650]], camposKey:0146-0404 2005-01-01 Ocular surface in vivo tolerance to new nanoparticulate polymer systems designed for drug delivery00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=641]], camposKey:1542-0124 2005-01-01 Pathways of corneal and ocular surface inflammation: A perspective from the Cullen Symposium131138, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=712]], camposKey:1528-4050 2005-01-01 The role of the conjunctival epithelium in ocular allergy441445, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39488]], camposKey:1542-0124 2005-01-01 Variation in the expression of inflammatory markers and neuroreceptors in human conjunctival epithelial cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=660]], camposKey:0002-9394 2004-12-01 Macular edema as the only ocular finding of tuberculosis10481049, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3559]], camposKey:0365-6691 2004-12-01 Ocular Behçet disease. Retrospective study Enfermedad de Behçet ocular. Estudio retrospectivo.599603, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56651]], camposKey:0146-0404 2004-04-01 Presence of alpha 2-adrenergic receptor subtypes in the normal human conjunctiva.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=749]], camposKey:0146-0404 2004-01-01 Comparison of antioxidant enzymes genes expression changes in conjunctival epithelium induced by non ionic hydrogel contact lenses with different oxigen permeability.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=748]], camposKey:0146-0404 2004-01-01 Comparison of mucin genes expression alterations in conjunctival epithelium induced by high and low water content hydrogel contact lenses.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=782]], camposKey:0146-0404 2004-01-01 Corneal thickness changes after one year of hydrogel contact lens00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=778]], camposKey:0014-4835 2004-01-01 Impression cytology of the ocular surface: a review457472, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13959]], camposKey:0365-6691 2004-01-01 Oftalmía simpática postvitrectomía tras traumatismo y taponamiento con perfluorocarbono líquido553556, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49629]], camposKey:0365-6691 2004-01-01 Sympathetic ophthalmia post-vitrectomy following trauma and perfluorocarbon liquid tamponade Oftalmía simpática postvitrectomía tras traumatismo y taponamiento con perfluorocarbono líquido.553556, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=645]], camposKey:1529-7322 2003-07-01 Animal models of ocular allergy and their clinical correlations345351, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55936]], camposKey:0146-0404 2003-05-01 Antioxidant enzyme genes expression in conjunctival epithelium of normal subjects00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56666]], camposKey:0146-0404 2003-05-01 Effect of IFN gamma on muscarinic and adrenergic receptor expression in a normal human conjunctival (NHC) epithelial cell line: Flow cytometry study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56668]], camposKey:0146-0404 2003-05-01 Expression of neurotransmitter receptors and Vip in conjunctival biopsies of vernal keratoconjunctivitis patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56664]], camposKey:0146-0404 2003-05-01 In vitro models of ocular inflammation using normal human conjunctival cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56667]], camposKey:0146-0404 2003-05-01 Western blot analysis of muscarinic and adrenergic receptors in a normal human conjunctival (NHC) epithelial cell line00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=737]], camposKey:0146-0404 2003-01-01 Alteration of conjunctival mucin gene expression in tear-deficient Dry Eye Syndrome00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53793]], camposKey:0146-0404 2003-01-01 Antioxidant Enzyme Genes Expression in Conjunctival Epithelium of Normal Subjects00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49633]], camposKey:0365-6691 2003-01-01 Can the use of intraocular silicone oil increase the risk of sympathetic ophthalmia? ¿Puede aumentar el riesgo de oftalmía simpática el uso intraocular de aceite de silicona?3942, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=758]], camposKey:0146-0404 2003-01-01 Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva42634274, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=745]], camposKey:0146-0404 2003-01-01 Comparison of central corneal thickness measured with ultrasonic pachometer, Orbscan (R) and OCT (R)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=687]], camposKey:0277-3740 2003-01-01 Human epithelium from conjunctival impression cytology expresses MUC7 mucin gene665671, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=781]], camposKey:0146-0404 2003-01-01 Levels of antioxidant enzyme genes in conjunctival impression cytology specimens from hydrogel contact lenses wearers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=723]], camposKey:0271-3683 2003-01-01 Levels of mucin gene expression in normal human conjunctival epithelium in vivo323328, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=770]], camposKey:0146-0404 2003-01-01 Low water content hydrogel contact lenses (HCL) induce corneal irregularity00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3560]], camposKey:0365-6691 2003-01-01 Normal human conjunctival epithelium expresses MUC13, MUC15, MUC16 and MUC17 mucin genes Expresión de los genes de mucinas MUC13, MUC15, MUC16 y MUC17 en el epitelio conjuntival normal humano in vivo.375381, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=775]], camposKey:0146-0404 2003-01-01 Prospective variation in the expression of the conjunctival mucin genes Muc5ac, Muc7, Muc16, and Muc17 before, during and after contact lens wear00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13969]], camposKey:0365-6691 2003-01-01 ¿Puede aumentar el riesgo de oftalmía simpática el uso intraocular de aceite de silicona?3942, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=28754]], camposKey:0365-6691 2003-01-01 Síntomas y signos de ojo seco en usuarios de lentes de contacto hidrofílicas: relación con el hábito de fumar543547, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56665]], camposKey:0146-0404 2002-05-01 Immunodetection of muscarinic and adrenergic receptors in an epithelial cell line from human conjunctiva00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=762]], camposKey:0146-0404 2002-01-01 Characterization of an epithelial cell line derived from normal human conjunctiva (NHC cell line)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=756]], camposKey:0146-0404 2002-01-01 Comparison of ocular surface alterations induced by high and low water content hydrogel contact lenses00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=744]], camposKey:0146-0404 2002-01-01 Cyclosporin A does not alter the expression of ocular mucin genes in a normal human conjunctival (NHC) cell line00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=710]], camposKey:0271-3683 2002-01-01 Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats3945, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=740]], camposKey:0065-2598 2002-01-01 Human conjunctival epithelium in culture: A tool to assay new therapeutic strategies for dry eye307311, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42335]], camposKey:0365-6691 2002-01-01 Ocular sarcoidosis. Retrospective study of 18 cases Sarcoidosis ocular. Estudio retrospectivo de 18 casos.301308, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=733]], camposKey:0146-0404 2002-01-01 Range of mucin gene expression in normal human conjunctival epithelium in vivo00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=785]], camposKey:1046-6673 2001-09-01 Creatine transport in brush-border membrane vesicles isolated from rat kidney cortex18191825, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=678]], camposKey:0927-3948 2001-09-01 Fuchs' heterochromic iridocyclitis: A review of 26 cases169175, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54147]], camposKey:0146-0404 2001-03-15 Is silicone oil intraocularly injected related to a higher prevalence of sympathetic ophthalmia?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=654]], camposKey:0039-6257 2001-03-01 The treatment of dry eye00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=793]], camposKey:0031-6768 2001-02-01 A Na+-dependent D-mannose transporter in the apical membrane of chicken small intestine epithelial cells686691, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3564]], camposKey:0365-6691 2001-01-01 Acute macular neuroretinopathy: a case report Neuro-retinopatía macular aguda: a propósito de un caso.319322, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3563]], camposKey:0365-6691 2001-01-01 In vitro toxicity of non-preserved artificial-tear formulations Lágrimas artificiales sin conservantes: estudio comparativo in vitro.613619, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=726]], camposKey:0927-3948 2001-01-01 Pars planitis: epidemiology, treatment, and association with multiple sclerosis93102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3565]], camposKey:0365-6691 2001-01-01 Usefulness of conjunctival biopsy as diagnostic technique Utilidad de la biopsia conjuntival como técnica diagnóstica.3136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41615]], camposKey:1395-3931 2000-01-01 Ocular allergies: Association with immune dermatitis6975, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41616]], camposKey:1395-3931 1999-01-01 Classification of ocular atopic/allergic disorders and conditions: An unsolved problem1013, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=724]], camposKey:0271-3683 1999-01-01 Ultrastructural evidence of mucus I human conjunctival epithelial cultures95105, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=721]], camposKey:0277-3740 1998-07-01 Carbomer- versus cellulose-based artificial-tear formulations: Morphologic and toxicologic effects on a corneal cell line433440, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42606]], camposKey:0365-6691 1998-01-01 Análisis retrospectivo de la eficacia de la cirugía en pacientes con uveítis367374, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=774]], camposKey:0277-3740 1998-01-01 Analysis of human ocular mucus: Effects of neuraminidase and chitinase enzymes200207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=734]], camposKey:0271-3683 1998-01-01 Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat3946, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=741]], camposKey:1080-7683 1998-01-01 Expression of ICAM-1 and HLA-DR by human conjunctival epithelial cultured cells and modulation by nedocromil sodium517531, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42607]], camposKey:0365-6691 1998-01-01 Queratitis inducida por el abuso de anestésicos tópicos: caso clínico5759, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41436]], camposKey:0146-0404 1997-12-01 Evaluation of chitosan as a substitute for the mucus layer of the preocular tear film00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=720]], camposKey:0721-832X 1997-05-01 Characterization of epithelial primary cultures from human conjunctiva268276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42614]], camposKey:0365-6691 1997-01-01 Alteraciones corneales y palpebrales en el síndrome de hiperlaxitud palpebral445452, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3570]], camposKey:0365-6691 1997-01-01 Diagnostic tests of blepharitis-associated dry-eye syndrome. Usefulness of topical anesthesia Test diagnosticos del sindrome de ojo seco asociado a blefaritis, utilidad de la anestesia topica437444, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42610]], camposKey:0365-6691 1997-01-01 Distribución de las uveítis en un centro de referencia665670, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41434]], camposKey:0146-0404 1997-01-01 Evidence of mucin production in cultured conjunctival epithelium00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=735]], camposKey:0146-0404 1997-01-01 In vitro study on the toxic effects of carbomer-derived versus carboxymethylcellulose (CMC)-derived artificial tear formulations upon corneal cells749749, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=667]], camposKey:0927-3948 1997-01-01 Influence of topical anesthesia on tests diagnostic of blepharitis-associated dry eye syndrome3342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55200]], camposKey:0365-6691 1997-01-01 Test diagnósticos del síndrome de ojo seco asociado a blefaritis: utilidad de la anestesia tópica437444, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42611]], camposKey:0365-6691 1997-01-01 Tinción diferencial mediante lectinas de la capa mucosa de la película lagrimal precorneal y hongos en un modelo animal de queratitis micótica1116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=698]], camposKey:0003-9950 1996-05-01 Referral patterns of uveitis in a tertiary eye care center593599, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41617]], camposKey:0146-0404 1996-01-01 Corneal incorporation of exogenous hyaluronic acid on a lamellar keratectomy animal model00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=709]], camposKey:1081-1206 1996-01-01 Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy124130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3573]], camposKey:0724-8741 1996-01-01 Erratum: Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A (Pharmaceutical Research, 13(2), 311-315, (1996))14230, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41437]], camposKey:0146-0404 1996-01-01 Nedocromil Sodium (NS) modulates ICAM-1 and HLA-DR expression of human conjunctival epithelial cells in vitro00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=700]], camposKey:0927-3948 1996-01-01 Phlyctenular keratoconjunctivitis - A potentially blinding disorder119123, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=634]], camposKey:0724-8741 1996-01-01 Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A311315, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39500]], camposKey:0146-0404 1995-03-15 CHARACTERIZATION OF HUMAN CONJUNCTIVAL EPITHELIAL-CELLS IN CULTURE00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41618]], camposKey:0277-3740 1995-01-01 Calcareous corneal degeneration: Report of two cases97102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40017]], camposKey:0146-0404 1995-01-01 Effect of the enzymes chitinase and neuraminidase on the structure of human ocular mucus00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=643]], camposKey:0271-3683 1995-01-01 Experimental model of allergic conjunctivitis to ragweed in guinea pig487494, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=658]], camposKey:0146-0404 1995-01-01 OCULAR PENETRATION OF 1-PERCENT CYCLOSPORINE (CYA) FROM NANOCAPSULES AND CONVENTIONAL FORMATIONS IN RABBIT EYES00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40666]], camposKey:0146-0404 1995-01-01 TOPICAL APPLICATION OF NANOCAPSULES OF CYCLOSPORINE-A (CYA) ON A PENETRATING KERATOPLASTY REJECTION MODEL00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=776]], camposKey:0146-0404 1994-01-01 Chromatographic purification of human ocular mucus and structural-analysis by enzymatic means17951795, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3574]], camposKey:0365-6691 1994-01-01 Comparative clinical trial of 2% hydroxypropyl-methylcellulose versus 1% sodium hyaluronate in extracapsular surgery ESTUDIO CLINICO COMPARATIVO DE LA HIDROXIPROPIL-METILCELULOSA 2% QUIRURGICA VERSUS HIALURONATO SODICO 1% EN LA CIRUGIA EXTRACAPSULAR DE CATARATA39, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43850]], camposKey:0365-6691 1994-01-01 Estudio clínico-comparativo de la hidroxipropil-metilcelulosa 2% quirúrgica versus hialuronato sódico 1% en la cirugía extracapsular de catarata310, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42620]], camposKey:0365-6691 1994-01-01 Factores clínicos que predisponen al fracaso de transplante de cornea: rechazo inmune659666, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42609]], camposKey:0365-6691 1994-01-01 Queratoplastia en el edema de córnea del afáquico: correlación clínico-patológica311318, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=747]], camposKey:0146-0404 1994-01-01 Sensitivity of human uveal melanoma cell-lines to the type-2 ribosome-inactivating proteins (rips) ricin, ebulin-1, and nigrin-b19271927, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41619]], camposKey:0161-6420 1993-01-01 Authors' reply293294, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=795]], camposKey:0021-9258 1993-01-01 Ebulin 1, a nontoxic novel type 2 ribosome-inactivating protein from Sambucus ebulus L. leaves.1819518199, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=773]], camposKey:0146-0404 1993-01-01 Enzymatic deglycosilation and electrophoretic analysis of the ocular mucus structure14691469, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=794]], camposKey:0167-4412 1993-01-01 Isolation and partial characterization of nigrin b, a non-toxic novel type 2 ribosome-inactivating protein from the bark ofSambucus nigra L.11811186, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=651]], camposKey:0277-3740 1992-01-01 Epidermal Growth Factor and Corneal Wound Healing: A Multicenter Study311314, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42467]], camposKey:0146-0404 1992-01-01 IS CHRONIC APPLICATION OF EYEDROPS RELATED WITH OCULAR ALLERGY850850, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=633]], camposKey:0277-3740 1992-01-01 Management of Corneal Complications in Xeroderma Pigmentosum173182, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=690]], camposKey:0161-6420 1992-01-01 Ocular Surface Alteration after Long-term Treatment with an Antiglaucomatous Drug10821088, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=657]], camposKey:0146-0404 1992-01-01 VASCULAR-PERMEABILITY DURING THE EARLY AND LATE PHASES OF OCULAR ANAPHYLAXIS5559, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=692]], camposKey:0146-0404 1991-03-15 ENHANCED OCULAR ANAPHYLAXIS IN THE GUINEA-PIG AFTER LONG-TERM, LOCALLY APPLIED DROPS683683, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=688]], camposKey:0146-0404 1991-03-15 MODIFICATION OF THE OCULAR SURFACE AFTER CHRONIC APPLICATION OF ANTIGLAUCOMATOUS DROPS947947, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55195]], camposKey:0365-6691 1991-01-01 Efecto de la instalación crónica de fármacos sobre la superficie conjuntival8996, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3575]], camposKey:0365-6691 1991-01-01 The effect of long-term drug applications on the eye surface8996, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=648]], camposKey:0161-6420 1990-01-01 Atopic Keratoconjunctivitis9921000, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41620]], camposKey:1755-375X 1990-01-01 Early and late phases of ocular anaphylaxis in actively immunized guinea pigs470476, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=637]], camposKey:0030-3747 1990-01-01 Effect of Topical Dexamethasone on the Ocular Allergic Reaction in Passively Sensitized Guinea Pigs351358, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42616]], camposKey:0365-6691 1990-01-01 Estandarización del estudio de la capa mucoide de la película lagrimal precorneal.453460, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42608]], camposKey:0365-6691 1990-01-01 Evaluación de la anteroposición reglada del oblicuo inferior269274, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=676]], camposKey:0146-0404 1990-01-01 Pharmacologic modulation of vascular permeability in ocular allergy in the rat176180][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19280]},camposKey: 231 262 Cell Therapy Using Extraocular Mesenchymal Stem Cells 978-3-030-01303-5Corneal Regeneration 1 2019-01-01 Springer, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=13804]},camposKey: 129 144 Síndrome de Ojo Seco 978-84-937878-3-7Superficie ocular y biomateriales: lentes de contacto 1 2017-01-01 Ulleye, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=112]},camposKey: 101 104 Chitosan-Based Colloidal Systems as Promising Topical Drug Carriers for Ocular Surface Disorders 978-88-7587-431-57th International Symposium on Ocular Pharmacology and Therapeutics 1 2008-01-01 Medimond International Proceedings, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=14830]},camposKey: 89 109 The conjunctiva and tear film maintenance 082474702XDry Eye and Ocular Surface Disorders 1 2004-06-23 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=113]},camposKey: 643 648 Immunosuppressive chemotherapy for non-infectious uveitis 88-323-0601-8SOE '97 1 1997-01-01 Monduzzi Editore, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=111]},camposKey: 33 36 Management of severe atopic keratoconjunctivitis 0444813675Ocular immunology today 1 1990-01-01 -][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=109076],camposKey=84-7762-099-7Anafilaxia conjuntival: desarrollo de un modelo experimental 1 1990-01-01 }][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61349]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=60991]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=60572]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61710]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61681]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61405]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61349]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=60991]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=60572]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61710]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61681]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61405]]][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30689]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638396]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638267]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638314]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636906]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636896]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636897]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636892]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145631907]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145635412]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145631228]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=69871]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145624855]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145627396]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626757]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626882]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@269b4922, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1cde6afb, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4e41938b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@333db2d0, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@17a68ff8, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@3835eee9][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da3bd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3d9372, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da3be, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@382d27, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da4a1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da1c8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3d940c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da49f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da4aa, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3751d0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375252, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da3c1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da395, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da497, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da498, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da4a7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da499, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da352, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da35e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da492, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da4ae, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da353, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da4a3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da355, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da1ca, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da49b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da191, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da358, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373343, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da393, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da357, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3d9f83, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da495, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3d9ec8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da3f6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373999, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da35d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3736a9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da1cb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da4a8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3d9f88, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da0c4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da356, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3739e2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da49e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da3c5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da3bf, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da392, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da2cc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3d954e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3d9e91, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373bc5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373427, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373bc2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da3f5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da3f9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37395c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da4b0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3d9f8a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37326d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da394, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b7d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da1ce, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ca3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da4a0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ca2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da193, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da35c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372be2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da18f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372b4d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372be1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da35b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372619, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372d65, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37309a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da3c3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@371f7d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372d66, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da496, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da1c9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da190, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3d9ec5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da493, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da49c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da494, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3d9400, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da354, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da49d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da359, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37300c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da35a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b92, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ae7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da4a2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3da194, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3730bf, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d76, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d5a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372a02, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373be0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d78, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b9f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d0c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3730d4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372acc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d8f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372ca0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372fe6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3734d4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3734f7][][][][][][com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1370]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1167]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1165]], com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1166]]][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4617f6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45fa3e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@414e9e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@462669], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f713], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f841], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41333e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412f1d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412570], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412fcd], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412577], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125ce], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413bdc], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412448], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125d6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412123], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4122bc], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460721], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411f50], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460600], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411db1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4120e4], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460477], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411ead], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411c9f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411c63], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f46f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412758], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412757], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f375], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41384e]][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@156ac, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1409c, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14081, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@142e1, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14802, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1480c, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@142a4][]

PUBLICACIONES

Artículos de revista (226)

Fernandez I.; Lopez-Miguel A.; Martin-Montañez V.; Enriquez-de-Salamanca A.; Calonge M.; Gonzalez-Meijome J.M.; Gonzalez-Garcia M.J. Inflammatory status predicts contact lens discomfort under adverse environmental conditions . OCULAR SURFACE 2020; 18(4): 829-84.

Enlace a la publicación
Ver Todos

Libros (1)


Ver Todos

Capítulos de libros (6)

Nieto-Miguel, Teresa ; Galindo, Sara ; López-Paniagua, Marina ; Pérez, Inmaculada ; Herreras, José M. ; Calonge, Margarita. Cell Therapy Using Extraocular Mesenchymal Stem Cells. En: Alió, Jorge L. del Barrio, Jorge L. Alió, Arnalich-Montiel, Francisco. Corneal Regeneration. Springer; 2019. p. 231-262

Enlace a la publicación

Ver Todos
 

AYUDA A LA INVESTIGACIÓN

Proyectos (31)

BIOMARCADORES DE INFLAMACIÓN EN LÁGRIMA COMO INDICADORES PREDICTIVOS DE GRAVEDAD Y EVOLUCIÓN EN LA INFECCIÓN POR COVID-19. . Equipo Investigadores: PASTOR JIMENO, JOSE CARLOS (IP); TAMAYO GOMEZ, EDUARDO; ALVAREZ GONZALEZ, FRANCISCO JAVIER; FERNANDEZ MARTINEZ, ITZIAR; ENRIQUEZ DE SALAMANCA Y ALADRO, AMALIA; MARTIN ASENJO, MIGUEL; DUEÑAS GUTIERREZ, CARLOS JESUS; CALONGE CANO, MARGARITA; GARCIA VAZQUEZ, MARIA DEL CARMEN. Personal Contratado: DIAZ GARCIA, RAQUEL. Entidades Participantes: UNIVERSIDAD DE VALLADOLID (UVa). Entidades Financiadoras: FONDOS FEDER, MINISTERIO DE CIENCIA, INNOVACIÓN Y UNIVERSIDADES, INSTITUTO DE SALUD CARLOS III, JUNTA DE CASTILLA Y LEÓN -CONSEJERÍA DE EDUCACIÓN. 2020-06-19 - 2021-10-15
Ver Todos

Convenios (111)

CONSULTAS, ACTOS TERAPÉUTICOS Y CIRUGÍAS COMPLEJAS EN EL CAMPO DE LA OFTALMOLOGÍA, SERVICIOS DE OPTOMETRÍA Y ADAPTACIÓN DE LENTES DE CONTACTO. COORDINACIÓN DE ENSAYOS CLÍNICOS. SERVICIOS DE ENFERMERÍA EN GESTIÓN DE PROYECTOS CLÍNICOS. . Equipo Investigadores: MALDONADO LOPEZ, MIGUEL JOSE (IP); SOBAS ABAD, EVA MARIA; PASTOR JIMENO, JOSE CARLOS; PEREZ CASTRILLON, JOSE LUIS; CALONGE CANO, MARGARITA; LOPEZ GALVEZ, MARIA ISABEL; GONZALEZ GARCIA, MARIA JESUS; MARTIN HERRANZ, RAUL; COCO MARTIN, ROSA MARIA; VELASCO GONZALEZ, VERONICA; LOPEZ MIGUEL, ALBERTO. Entidades Participantes: FUNDACION GENERAL DE LA UNIVERSIDAD DE VALLADOLID.. Entidades Financiadoras: FUNDACION GENERAL DE LA UVA.. 2021-01-01
Ver Todos

Otras ayudas y becas (6)

CONTRATO GARANTÍA JUVENIL JCYL TIPO A (FP) DE OLIVEROS GUTIEZ, DIEGO: ¿ Gestión, mantenimiento de un laboratorio de investigación; realización de pedidos,¿ Mantenimiento y preparación de los equipos de trabajo¿ Planificación y ejecución de experimentos¿ Preparación de disoluciones, colorantes y otros reactivos¿ Desarrollo de cultivos celulares y tisulares:- Cultivo de líneas celulares y de células madre mesenquimales humanas- Establecimiento de cultivos primarios a partir de tejidos- Estudios de adhesión, viabilidad y proliferación celular de líneas celulares y/o de cultivos primarios.. CALONGE CANO, MARGARITA (Director). OLIVEROS GUTIEZ, DIEGO (Beneficiario). 15/04/2021 - 2022-12-01. 37.000,00 EUR.
Ver Todos
 

OTROS

Tesis doctorales (16)


 
Ver Todos

Congresos (6)

ARVO 2013, FLORIDA ( ESTADOS UNIDOS DE AMÉRICA ) 04/05/2013 -
(Asistencia). CALONGE CANO, MARGARITA. ARVO 2013
Ver Todos

Patentes (4)

Margarita Calonge Cano, Maria José Cocero Alonso, Maria Jesús González García, Soraya Rodríguez Rojo, Nikolaos Katsinas. COMPUESTOS PARA SU USO EN LA PREVENCIÓN Y/O TRATAMIENTO DE LA INFLAMACIÓN Y EL ESTRÉS OXIDATIVO DEL SEGMENTO ANTERIOR DEL OJO. P202031306. 2020
Ver Todos
Cargando información ...
Universidad de Valladolid - Copyright Universidad de Valladolid - Todos los derechos reservados